What is ApoB

Apolipoprotein B (ApoB) is a protein that helps carry fats and cholesterol in your blood. Imagine it as a cargo ship that transports fat and cholesterol to different parts of your body. ApoB is a key part of "bad cholesterol" or LDL, which can cause problems if there's too much of it.

If there are too many of these ApoB cargo ships, they can drop off too much cholesterol in your blood vessels. This can lead to the buildup of plaque, like debris blocking a river, making it harder for blood to flow. This can increase the risk of heart attacks and strokes, i.e. ApoB is causally related to atherosclerosis.

So, ApoB is important because it helps us understand how much "bad cholesterol" is in the blood and helps doctors figure out the risk of heart disease.

ApoB vs. LDL: Why ApoB is a better measure of Cardiovascular Risk

ApoB and LDL cholesterol are both important markers for assessing cardiovascular risk, but ApoB is often considered a better measure for several reasons:

Particle Count

• ApoB: Each ApoB molecule represents one LDL particle. High levels of ApoB mean there are many LDL particles, even if the total cholesterol isn't very high.
• LDL Cholesterol: Measures the total amount of cholesterol within LDL particles, but doesn't tell you how many particles there are.

Particle Size

• ApoB: High ApoB levels indicate a large number of LDL particles, regardless of their size. Small, dense LDL particles are more atherogenic (more likely to cause plaque buildup) than larger ones.
• LDL Cholesterol: Can be misleading if someone has many small, dense LDL particles but a relatively normal total cholesterol level.

Why is particle size and count more important than knowing the total amount of cholesterol?

Knowing the number of particles (as measured by ApoB) is more important than knowing the total amount of cholesterol in those particles (as measured by LDL cholesterol) for several reasons:

Particle Penetration

• ApoB: Each LDL particle has the potential to penetrate the artery wall and contribute to plaque formation. A higher number of particles increases the chance of this happening, even if each particle carries a small amount of cholesterol.
• LDL Cholesterol: Total LDL cholesterol might be normal, but if it's carried in many small particles, the risk remains high because more particles can interact with the artery walls.

Atherogenicity

• ApoB: Small, dense LDL particles are more atherogenic (more likely to cause plaque buildup) than larger ones. High ApoB indicates more particles, which could mean more small, dense LDL particles, posing a greater risk.
• LDL Cholesterol: Doesn't differentiate between large, less harmful particles and small, more harmful ones. Someone with large LDL particles might have the same total LDL cholesterol as someone with small, dense particles, but the latter has a higher risk.

Studies have shown that ApoB is a stronger predictor of cardiovascular events (like heart attacks) compared to LDL cholesterol. It better correlates with the risk of developing cardiovascular diseases.

• ApoB: Provides a direct count of atherogenic particles, offering a clearer picture of the number of particles that can potentially penetrate artery walls and contribute to plaque formation.
• LDL Cholesterol: May underestimate cardiovascular risk in people with small, dense LDL particles and overestimate it in those with larger LDL particles.

Measuring Apolipoprotein B

Diagnostic Techniques

To measure Apolipoprotein B (ApoB) levels, doctors use a simple blood test. This test can be done at the same time as other blood tests, such as a lipid panel, which measures cholesterol and triglycerides. The blood sample is sent to a lab, where it is analyzed to determine the amount of ApoB in the blood.

The results of the ApoB test are usually given in milligrams per deciliter (mg/dL). A high ApoB level indicates that there are many lipoprotein particles, like LDL, in the blood, which can increase the risk of cardiovascular disease.

Reference Ranges

The reference range for ApoB levels can vary slightly depending on the laboratory and the population being tested, but generally, the following ranges are used:

• Optimal: Less than 60 mg/dL
• Normal: 61-90 mg/dL
• Borderline high: 90-99 mg/dL
• High: 100-119 mg/dL
• Very high: 120 mg/dL or above

It's important to note that these values are used to assess the risk of cardiovascular disease. Higher ApoB levels are associated with an increased risk of developing conditions like atherosclerosis, heart disease, and stroke.

While having ApoB levels below 60mg/dL is ideal, its simply a snapshot of your lipid status at one point in time. A more comprehensive approach involves examining the area under the curve (AUC) of apoB levels plotted against time or age. This method captures the cumulative exposure to high apoB levels over a period, which is crucial because CVD risk is influenced by long-term exposure to elevated lipoprotein levels.

By considering the AUC, we gain insights into the duration and magnitude of apoB exposure, not just a single measurement. This approach reflects the chronic nature of lipid buildup in arteries, which is a key factor in atherosclerosis development. In essence, the AUC method offers a more nuanced and accurate prediction of CVD risk by accounting for the sustained impact of apoB on cardiovascular health over time.

For example, someone who's ApoB levels have stayed consistently at 60mg/dL their whole life is at lower risk than someone who's ApoB levels were at 90mg/dL for half their life and 60mg/dL the other half.

What causes high ApoB?

Most of us have ApoB levels of around 20mg/dL when we’re babies but will see that concentration escalate swiftly after the age of 20 due to a variety of factors, which generally revolve around metabolic health and diet influences:

• Dietary Factors: Diets high in saturated fats, trans fats, and cholesterol can contribute to elevated ApoB levels. Highly processed foods and high sugar intake can also be significant contributors.
• Insulin Resistance and Metabolic Syndrome: These conditions are closely related to higher ApoB levels. Insulin resistance can lead to increased production of VLDL (very low-density lipoprotein) particles in the liver, which are rich in ApoB.
• Obesity: Excess body weight, particularly visceral fat, can influence ApoB levels. Fat tissue can alter lipid metabolism, leading to increased production and decreased clearance of ApoB-containing lipoproteins.
• Inflammation: Chronic inflammation can affect lipid metabolism and lead to higher ApoB levels. Inflammatory markers can alter the production and breakdown of lipoproteins.
• Thyroid Function: Hypothyroidism (low thyroid hormone levels) can lead to increased ApoB levels. Thyroid hormones play a significant role in lipid metabolism.
• Lifestyle Factors: Lack of physical activity, smoking, and excessive alcohol consumption can also contribute to elevated ApoB levels.
• Genetics: Some individuals may have genetic predispositions that cause higher ApoB levels. Conditions such as familial hypercholesterolemia can result in elevated ApoB levels despite lifestyle choices.

How to Lower ApoB

Dietary Modifications

Dietary modifications play a crucial role in managing and lowering ApoB levels. These changes can positively influence lipid metabolism, reducing the risk of cardiovascular diseases. Here are detailed strategies for dietary modifications:

A. Reducing Saturated Fats

• Sources of Saturated Fats:
  • Common sources include red meat, full-fat dairy products, butter, coconut oil, and processed foods like pastries and cookies.
• Impact on ApoB Levels:
  • Saturated fats directly impacts cholesterol synthesis and can increase low-density lipoprotein (LDL) cholesterol, which is rich in ApoB. Higher intake of saturated fats is associated with increased ApoB levels, leading to a higher risk of atherosclerosis and cardiovascular diseases.

B. Minimize Carbohydrates & Choose Low-Glycemic Foods

Avoiding starchy and refined carbohydrates is one of the most effective ways to reduce one’s triglycerides which is a proxy for insulin resistance.

• Understanding Glycemic Index:
  • The glycemic index (GI) measures how quickly a carbohydrate-containing food raises blood glucose levels. Foods with a low GI (55 or less) are digested and absorbed more slowly, leading to a gradual rise in blood sugar and insulin levels.
• Effects on Lipid Metabolism:
  • Low-GI foods help maintain stable blood sugar levels, reducing the likelihood of insulin resistance, which is associated with higher ApoB levels. These foods include whole grains, legumes, non-starchy vegetables, and most fruits.

C. Increasing Fiber Intake

• Types of Dietary Fiber:
  • Soluble fiber: Found in oats, barley, fruits like apples and pears, and vegetables such as carrots and broccoli.
  • Insoluble fiber: Present in whole grains, nuts, seeds, and the skins of fruits and vegetables.
• Mechanisms of Fiber in Lowering ApoB:
  • Soluble fiber binds to bile acids in the intestines, leading to their excretion. This process forces the body to use cholesterol to produce more bile acids, thus reducing the amount of LDL cholesterol and ApoB.
  • Fiber also slows down the absorption of cholesterol and fats, contributing to lower ApoB levels.

D. Incorporating Healthy Fats

• Sources of Unsaturated Fats:
  • Monounsaturated fats: Olive oil, avocados, nuts, and seeds.
  • Polyunsaturated fats: Fatty fish (salmon, mackerel, sardines), flaxseeds, walnuts, and soybean oil.
• Benefits of Omega-3 Fatty Acids:
  • Omega-3 fatty acids, particularly EPA and DHA found in fish oil, have been shown to reduce triglycerides and ApoB levels. They help improve the lipid profile by reducing inflammation and improving endothelial function.

Lifestyle Changes

In addition to dietary modifications, adopting specific lifestyle changes can significantly impact ApoB levels and overall cardiovascular health. Here are detailed strategies:

A. Regular Physical Activity

• Types of Exercises Recommended:
  • Aerobic Exercise: Activities such as brisk walking, running, cycling, and swimming. Aim for at least 150 minutes of moderate-intensity or 75 minutes of high-intensity aerobic exercise per week.
  • Resistance Training: Strength-training exercises using weights, resistance bands, or body weight. Perform resistance training at least two days per week to improve muscle mass and metabolism.
  • Flexibility and Balance Exercises: Activities like yoga and Pilates can improve overall fitness and reduce stress, indirectly benefiting cardiovascular health.
• Exercise’s Impact on Lipid Levels:
  • Regular physical activity helps increase high-density lipoprotein (HDL) cholesterol, which can aid in the removal of LDL cholesterol from the bloodstream.
  • Exercise improves insulin sensitivity, reducing the risk of insulin resistance and its associated increase in ApoB levels.
  • Physical activity aids in weight management, which is crucial for maintaining healthy lipid levels and reducing ApoB.

B. Weight Management

• Strategies for Achieving and Maintaining a Healthy Weight:
  • Balanced Diet: Combine dietary modifications with portion control to create a calorie deficit and promote weight loss.
  • Regular Exercise: Incorporate both aerobic and resistance training exercises to burn calories and build muscle.
  • Behavioral Changes: Adopt mindful eating practices, set realistic goals, and monitor progress through regular weigh-ins and food diaries.
  • Professional Support: Seek guidance from dietitians, nutritionists, or weight management programs for personalized advice and support.
• Relationship Between Weight Loss and ApoB Reduction:
  • Losing excess weight can lower LDL cholesterol and ApoB levels. Even a modest weight loss of 5-10% of body weight can significantly improve lipid profiles.
  • Weight management helps reduce visceral fat, which is linked to higher ApoB levels and cardiovascular risk.

C. Smoking Cessation

• Impact of Smoking on ApoB:
  • Smoking damages the endothelium (inner lining of blood vessels), leading to inflammation and an increase in ApoB-containing lipoproteins.
  • Smokers tend to have higher LDL cholesterol and lower HDL cholesterol levels, contributing to elevated ApoB.
• Resources and Strategies for Quitting Smoking:
  • Nicotine Replacement Therapy (NRT): Products like nicotine patches, gums, and lozenges can help manage withdrawal symptoms.
  • Medications: Prescription medications such as varenicline (Chantix) and bupropion (Zyban) can assist in smoking cessation by reducing cravings and withdrawal symptoms.
  • Counseling and Support Groups: Behavioral therapy, support groups, and smoking cessation programs provide emotional and psychological support.
  • Mobile Apps and Online Resources: Utilize apps and websites designed to help track progress, provide tips, and offer support for quitting smoking.

Additional Lifestyle Considerations

• Stress Management:
  • Chronic stress can negatively impact lipid levels and ApoB. Incorporate stress-reducing activities such as meditation, deep breathing exercises, hobbies, and spending time in nature.
• Sleep Quality:
  • Poor sleep can contribute to weight gain and negatively affect lipid metabolism. Aim for 7-9 hours of quality sleep per night by establishing a consistent sleep routine and creating a restful sleep environment.
• Alcohol Consumption:
  • Moderate alcohol consumption may have some cardiovascular benefits, but excessive drinking can increase triglycerides and ApoB levels. Limit alcohol intake to moderate levels—up to one drink per day for women and up to two drinks per day for men.

Pharmacological Interventions

For individuals who struggle to lower ApoB levels through diet and lifestyle changes alone, pharmacological interventions can be highly effective. This section details the primary medications used to manage and reduce ApoB levels, along with their mechanisms, effectiveness, and considerations.

A. Statins

• How Statins Work:
  • Statins inhibit the enzyme HMG-CoA reductase, which is critical for cholesterol synthesis in the liver. This inhibition reduces the production of cholesterol, leading to an increase in LDL receptors on liver cells, which in turn clears LDL cholesterol from the bloodstream.
  • Statins also have anti-inflammatory properties that can stabilize plaques in the arteries.
• Effectiveness in Lowering ApoB:
  • Statins are highly effective at lowering LDL cholesterol, which contains ApoB. Common statins include atorvastatin, rosuvastatin, and simvastatin.
  • Clinical studies have shown that statins can reduce LDL cholesterol levels by 20-55%, significantly lowering ApoB levels and reducing cardiovascular risk.
• Common Side Effects:
  • Potential side effects include muscle pain, liver enzyme abnormalities, and increased risk of diabetes in susceptible individuals.
  • Regular monitoring of liver function and muscle enzymes is recommended for patients on statins.

B. PCSK9 Inhibitors

• Mechanism of Action:
  • PCSK9 inhibitors are monoclonal antibodies that target and inhibit the PCSK9 protein, which degrades LDL receptors on liver cells. By inhibiting PCSK9, more LDL receptors are available to remove LDL cholesterol from the blood.
  • Examples of PCSK9 inhibitors include alirocumab and evolocumab.
• Clinical Studies and Results:
  • PCSK9 inhibitors can reduce LDL cholesterol levels by up to 60%, leading to significant reductions in ApoB levels.
  • They are particularly beneficial for individuals with familial hypercholesterolemia or those who cannot tolerate statins.
• Administration and Side Effects:
  • PCSK9 inhibitors are administered via subcutaneous injections every two to four weeks.
  • Common side effects include injection site reactions, flu-like symptoms, and upper respiratory tract infections.

C. Other Lipid-Lowering Medications

• Ezetimibe:
  • Mechanism of Action: Ezetimibe reduces the absorption of cholesterol in the intestines by inhibiting the NPC1L1 transporter. It can be used alone or in combination with statins.
  • Effectiveness: Ezetimibe can lower LDL cholesterol by 15-20% and further reduce ApoB levels when combined with statins.
  • Side Effects: Generally well-tolerated, but some individuals may experience gastrointestinal symptoms.
• Bile Acid Sequestrants:
  • Mechanism of Action: These medications bind bile acids in the intestines, preventing their reabsorption. This forces the liver to use more cholesterol to produce bile acids, thereby lowering LDL cholesterol levels.
  • Examples: Cholestyramine, colesevelam, and colestipol.
  • Effectiveness: Can reduce LDL cholesterol by 10-20%, but are less commonly used due to gastrointestinal side effects such as constipation and bloating.
• Niacin (Vitamin B3):
  • Mechanism of Action: Niacin inhibits the liver’s production of LDL and very low-density lipoprotein (VLDL) cholesterol. It can also increase HDL cholesterol.
  • Effectiveness: Niacin can reduce ApoB levels by 10-20% and triglycerides by 20-50%.
  • Side Effects: Flushing, gastrointestinal upset, and potential liver toxicity at high doses. Regular monitoring of liver function is necessary.
• Fibrates:
  • Mechanism of Action: Fibrates activate peroxisome proliferator-activated receptors (PPARs) which increase the oxidation of fatty acids and reduce triglyceride levels.
  • Examples: Fenofibrate and gemfibrozil.
  • Effectiveness: Primarily used to lower triglycerides, but can also modestly reduce ApoB levels. They are particularly useful for individuals with high triglycerides and low HDL cholesterol.
  • Side Effects: Gastrointestinal disturbances, gallstones, and potential interactions with statins that can increase the risk of muscle damage.

Combining Medications for Optimal Results

• Combination Therapy:
  • For individuals with very high ApoB levels or those who do not achieve target levels with a single medication, combination therapy may be necessary. This often involves using statins with ezetimibe or PCSK9 inhibitors.
  • Combination therapy can provide a synergistic effect, further lowering LDL cholesterol and ApoB levels.
• Personalized Treatment Plans:
  • Treatment plans should be tailored to individual needs, considering factors such as the severity of hyperlipidemia, presence of comorbidities, and tolerance to medications.
  • Regular follow-ups and lipid profile monitoring are essential to adjust the therapy as needed.

Pharmacological interventions can be a powerful tool in lowering ApoB levels, particularly when combined with lifestyle and dietary modifications. These medications should be used under the guidance of a healthcare professional to ensure safety and efficacy.

Nutritional Supplements

Nutritional supplements can play a supportive role in lowering ApoB levels, especially when combined with dietary and lifestyle changes. This section explores various supplements that have been shown to impact lipid metabolism and ApoB levels.

A. Plant Sterols and Stanols

• Sources and Benefits:
  • Plant sterols and stanols are naturally occurring substances found in small amounts in many fruits, vegetables, nuts, seeds, cereals, and legumes. They are also available as supplements and are added to certain foods like margarine, orange juice, and yogurt.
  • These compounds are structurally similar to cholesterol and compete with cholesterol for absorption in the digestive system.
• Mechanism of Action:
  • By blocking the absorption of dietary cholesterol, plant sterols and stanols reduce the overall cholesterol levels in the blood. This includes a reduction in LDL cholesterol, which contains ApoB.
• Recommended Dosages:
  • The recommended intake for lowering cholesterol is 2-3 grams per day. This can be achieved through fortified foods or supplements.
• Effectiveness:
  • Regular consumption of plant sterols and stanols can lower LDL cholesterol by 6-15%, contributing to a reduction in ApoB levels.

B. Soluble Fiber Supplements

• Types and Effectiveness:
  • Common soluble fiber supplements include psyllium husk, beta-glucan from oats and barley, and pectin from fruits.
• Mechanism of Action:
  • Soluble fiber binds to bile acids in the intestines, which are then excreted from the body. This forces the liver to use cholesterol to produce more bile acids, lowering the levels of LDL cholesterol and ApoB.
• Recommended Dosages:
  • Consuming 5-10 grams of soluble fiber per day can significantly lower LDL cholesterol. Psyllium supplements, for instance, typically recommend 7-10 grams per day, divided into multiple doses.
• Effectiveness:
  • Regular intake of soluble fiber can reduce LDL cholesterol by 5-10%, contributing to lower ApoB levels.

C. Omega-3 Fatty Acids

• Sources and Supplementation Guidelines:
  • Omega-3 fatty acids, primarily EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are found in fatty fish (such as salmon, mackerel, and sardines), flaxseeds, chia seeds, and walnuts. They are also available as fish oil supplements and algae-based supplements for vegetarians.
• Mechanism of Action:
  • Omega-3 fatty acids reduce triglyceride levels by decreasing the rate of triglyceride synthesis in the liver. They also improve endothelial function and reduce inflammation.
• Recommended Dosages:
  • The American Heart Association recommends 1 gram of EPA and DHA per day for individuals with heart disease. Higher doses (2-4 grams per day) may be needed for significant triglyceride reduction.
• Effectiveness:
  • Omega-3 supplementation can reduce triglycerides by 20-50% and has a modest impact on reducing ApoB levels, particularly in individuals with high triglycerides.

D. Red Yeast Rice

• Source and Composition:
  • Red yeast rice is a traditional Chinese food and medicine made by fermenting rice with the yeast Monascus purpureus. It contains monacolin K, which is chemically identical to the active ingredient in lovastatin, a prescription statin.
• Mechanism of Action:
  • Similar to statins, monacolin K inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver.
• Recommended Dosages:
  • Typical doses of red yeast rice supplements range from 1,200 to 2,400 mg per day, divided into two doses.
• Effectiveness:
  • Red yeast rice can lower LDL cholesterol by 15-25%, contributing to reduced ApoB levels. It offers a natural alternative to statins for some individuals.
• Side Effects and Considerations:
  • Potential side effects include muscle pain, liver enzyme elevation, and interactions with other medications. It’s important to use high-quality products to avoid contaminants like citrinin, a harmful substance that can be present in some red yeast rice products.

E. Policosanol

• Source and Composition:
  • Policosanol is a natural substance derived from the waxy coating of sugar cane, yams, or beeswax.
• Mechanism of Action:
  • Policosanol may inhibit cholesterol synthesis in the liver and enhance the breakdown of LDL cholesterol.
• Recommended Dosages:
  • Typical doses range from 5 to 20 mg per day, usually taken in divided doses.
• Effectiveness:
  • Studies on policosanol’s effectiveness are mixed, with some showing significant reductions in LDL cholesterol and ApoB levels, while others show minimal impact. More research is needed to confirm its efficacy.
• Safety and Side Effects:
  • Policosanol is generally well-tolerated, with few reported side effects. However, its effectiveness may vary among individuals.

F. Coenzyme Q10 (CoQ10)

• Source and Supplementation:
  • CoQ10 is a naturally occurring antioxidant found in the body, particularly in the heart, liver, and kidneys. It is also available as a dietary supplement.
• Mechanism of Action:
  • While CoQ10 itself does not directly lower ApoB levels, it is often used in conjunction with statin therapy to reduce the muscle pain associated with statin use.
• Recommended Dosages:
  • Typical doses range from 100 to 300 mg per day.
• Effectiveness:
  • CoQ10 supplementation can improve muscle symptoms in patients on statins, potentially enhancing adherence to statin therapy and indirectly supporting the reduction of ApoB levels.

Incorporating these nutritional supplements can provide additional support in lowering ApoB levels. However, it’s essential to consult with a healthcare provider before starting any new supplement regimen to ensure safety and appropriate usage.

Emerging Therapies

Research is ongoing to develop new ways to manage ApoB levels. Gene therapy and RNA-based treatments are among the promising areas of study. These therapies aim to target the genetic and molecular mechanisms that control ApoB production and metabolism, potentially offering more effective and long-lasting solutions.

Cost of ApoB Testing

Unlike standard cholesterol tests, a specific blood test is needed to measure apoB. In Canada, this test is not included in a typical lipid panel, which makes it essential to request it separately. As it is not covered by OHIP, the cost is usually $20 to $40 depending on the lab provider. Both our longevity panel and metabolic panel includes testing for apoB.

Measuring ApoB levels through blood tests provides a clearer picture of cardiovascular risk compared to traditional cholesterol tests. This allows for better diagnosis and monitoring of heart disease, especially in individuals with genetic conditions affecting lipid metabolism. By understanding and managing ApoB, we can take proactive steps towards better heart health and overall well-being.

Disclaimer: This blog post is intended for educational purposes only and should not be taken as medical advice. Always consult your healthcare provider for personal health concerns.